Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

L

Leeuwenhoek Laboratories Co. Ltd.

Status

Not yet enrolling

Conditions

Metabolic Syndrome

Study type

Observational

Funder types

Industry

Identifiers

NCT06363864
LL-IRB-2401

Details and patient eligibility

About

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

Enrollment

1,200 estimated patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Capable adults weigh ≥ 50 kg

Exclusion criteria

  • Not Taiwanese
  • Having received oral antibiotics, immunosuppressants, and chemotherapy drugs in the past month
  • Incapacity
  • Limited disposing capacity
  • Mental disorders or intellectual disabilities

Trial design

1,200 participants in 2 patient groups

Healthy individuals
Metabolic syndrome patients

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems